Tissue Microarray Market is Expected to Witness Significant Growth and Research Report 2027

The Tissue Microarray (TMA) Market, although still in its embryonic stage, it is growing rapidly.  The advent of tissue microarray in genomics and proteomics is a key driving force behind the growth of the market.  Moreover, emerging applications of tissue microarray technology in genotyping, mutation screening, protein interaction studies, and gene expression analysis are escalating the market on the global platform.

Considering the exponential traction, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global tissue microarray market will reach an exponential valuation by 2023, registering a staggering CAGR over 10% throughout the forecast period (2017-2023).

The tissue microarray technology is also been used in the diagnosis of various diseases, which eventually aid in determining better treatment strategies. Moreover, TMA also finds extensive applications in the healthcare sector. Also, various properties of TMA such as portability, rapid assay times, and fewer sample requirements have widened its adoption despite it being an expensive technology.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1213 

The advent of tissue microarray technologies for genomics and proteomics, histopathology research received a similar much-needed boost by the introduction of tissue microarray technology (TMA). On the other hand, factors such as the challenges related to the heterogeneity of antigen expression of TMA in histopathological research are impeding the growth of the market.

Key Players

Some of the eminent companies which are operating in the global tissue microarray market are enlisted by MRFR. They are; OriGene Technologies Inc (U.S), Abcam plc (U.K), Asterand Bioscience (U.S), Externautics (Italy), Protein Biotechnologies Inc. (U.S), US Biomax Inc. (U.S), Auria Biopankki (Finland), Novus Biologicals, LLC (U.S), and OriGene Technologies Inc.(U.S). and Others


MRFR in the segmental study of the tissue microarray market covers the crucial aspects of the market. The market has been studied under the segments of procedure, technology, and applications.

  • Based on the procedure, the tissue microarray market has been segmented into Frozen Tissue Array, Immunohistochemistry, and Fluorescent In-Situ Hybridization.
  • Based on the technology, the tissue microarray market has been segmented into Next-Generation Sequencing, DNA Microarray, Western Blotting, Polymerase Chain Reaction (PCR), and Northern Blotting.
  • Based on the application, the microarray market has been segmented into Gene Expression Profiling, Comparative Genomic Hybridization, SNP Detection, Sequencing Bioinformatics, Double-Stranded B-DNA Microarrays, and Oncology.
  • Based on the end-use, the microarray market has been segmented into research organization and pharmaceutical and biotechnological companies.

Regional Analysis

The North American region, heading with the presence of a number of biotechnology and pharmaceutical companies and a well-developed healthcare sector dominates the global tissue microarray market followed by the European and Asia Pacific region, respectively.  Simultaneously, factors such as the huge demand for TMA in the high-volume R&D activities led by the funding from the public and private sectors.

Undoubtedly, the availability and the wide uptake of new technologies in the development of targeted therapeutics using tissue microarray technologies is positively impacting market growth. The US, backed by the huge technological advancements in the field of manufacturing biologics leads the regional market.

Moreover, the availability of advanced infrastructures for healthcare along with the availability of skilled healthcare professional is boosting the growth of the market. Furthermore, factors such as the strong economy in the region that is leading to huge developments in the healthcare domain, and focus of research institutions on updating technology for new and advanced diagnosis and treatment methods.

The European region owns the next largest share in the global tissue microarray market, following the North American market closely.  Factors propelling the growth of the regional market include the increasing emphasis on rapid diagnosis & treatments of cancer and the prevalence of infectious diseases & cancer among the geriatric population.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213 

The Asia Pacific region is emerging as a profitable market for tissue microarray due to the rapidly improving healthcare infrastructure. Moreover, factors such as the ever-increasing population that is continually dictating the demand for quality healthcare and the spreading awareness are positively impacting the growth in the regional market.

Rapidly developing economies are expected to provide immense opportunities for the growth of TMA. Also, the increasing adoption of technologies is positively impacting market growth in the region. Furthermore, rising healthcare concerns along with the fast-proliferating healthcare sector, increase the market size of the tissue microarray market in the APAC.

Comments are closed